Reducing prescription drug costs for seniors: The ABCs of ASP for Part D
As we move into 2021, it is time to take stock of the myriad proposals related to making prescription drugs more affordable for patients. Both political...
Kirsten works with leaders in healthcare helping to develop business practices that lead to greater access to affordable medicines, positive public perception, and sustained profitability to support investment in the next generation of innovation.
Kirsten sat on the leadership team of Pfizer Inc’s $30 billion global innovative pharmaceutical business, where she led Strategy and Business Evaluation. Previously, Kirsten led Pfizer’s Global Policy team. She is a visiting scholar with the American Enterprise Institute, an Aspen Institute Health Innovator Fellow, and a senior advisor to Charles River Associates.
Kirsten recently climbed Mt. Kilimanjaro to raise $1.6 million for cancer research with a team of biotech CEOs and investors.